activins has been researched along with Heritable Pulmonary Arterial Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humbert, M | 1 |
| Azam, T; Baumer, Y; Boisvert, WA; Botti, P; Cho, SX; Cool, CD; Dinarello, CA; Dinkel, H; Farkas, L; Heinhuis, B; Joosten, LA; Marasco, D; Nold, MF; Nold-Petry, CA; Palmer, BE; Rudloff, I; Ruvo, M; Taraseviciene-Stewart, L; Voelkel, NF; Zepp, JA | 1 |
2 other study(ies) available for activins and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
Topics: Activins; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Pulmonary Arterial Hypertension | 2023 |
IL-32 promotes angiogenesis.
Topics: Activins; Animals; Apoptosis; Cells, Cultured; Endostatins; Familial Primary Pulmonary Hypertension; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Integrin alphaVbeta3; Interferon-gamma; Interleukin-8; Interleukins; Matrix Metalloproteinase 9; Mice; Neovascularization, Pathologic; Nitrogen Oxides; Receptors, Vascular Endothelial Growth Factor; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2014 |